Navigation Links
$2.8 million grant boosts cystic fibrosis research at Queen's
Date:2/4/2011

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a 1.74 million US-Ireland Research and Development Partnership grant.

The grant has been approved by the National Institutes of Health (NIH) in the USA with funding for the Queen's component provided by Health and Social Care Research and Development (HSC R&D Public Health Agency), Northern Ireland and the Medical Research Council. The grant is the largest ever to be awarded in the UK to study the microbiology of Cystic Fibrosis pulmonary infection.

The study is a collaborative US-Ireland international study with researchers in the Royal College of Surgeons Ireland, Dublin, the University of North Carolina at Chapel Hill, USA and the School of Pharmacy and the Centre for Infection and Immunity at Queen's University, Belfast.

Leading the study, Professor Stuart Elborn, Director of the Centre for Infection and Immunity in the School of Medicine, Dentistry and Biomedical Sciences at Queen's said; "The key goals of this study are to find out the role of anaerobes in causing damage to the lungs of people with Cystic Fibrosis. Anaerobes are bacteria that do not need oxygen to survive and we will determine whether their presence in the lung contributes to infection there.

We will also examine whether the bacteria are able to produce chemicals that can damage lung tissue and break down antibiotics given to treat lung infection. We will also look at how effective different antibiotics are in treating them."

He added; "The results of the study will be of important clinical relevance to people with Cystic Fibrosis because if we show that these anaerobes are contributing to infection and inflammation in the lungs of Cystic Fibrosis patients, in the future, patients could potentially be given more appropriate and effective antibiotics which should improve their clinical outcome and quality of life."

The research project has been funded for five years with an aim of recruiting a total of 450 Cystic Fibrosis patients across the three sites. The work will be performed in the 'US-Ireland Anaerobe Laboratory' in the Medical Biology Centre which has been recently refurbished - specifically to facilitate the delivery of this project.


'/>"/>

Contact: Claire O'Callaghan
c.ocallaghan@qub.ac.uk
44-289-097-5391
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
2. UofL Area Health Education Centers faculty, students make $6.8 million economic impact
3. Philanthropist invests $3.5 million in Buck Institutes Alzheimers drug development effort
4. 6 million euros for European Diabetes Research Network
5. 105 Million in U.S. Have Diabetes or Prediabetes, CDC Says
6. McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world
7. Khalifa Foundation grants MD Anderson $150 million for cancer research
8. LSTM leads new £6 million ($9.3 million) health systems knowledge consortium
9. NARSAD announces $12.6 million for new generation of brain and behavior research
10. Violence against mothers linked to 1.8 million female infant and child deaths in India
11. U.S. Spending Millions to See if Herbs Truly Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Washington, DC (PRWEB) , ... February 11, 2016 ... ... announce an upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study ... a not-for-profit Catholic health care system that’s partnering with Intel on value-based health ...
(Date:2/11/2016)... Mount Laurel, NJ (PRWEB) , ... February 11, ... ... Commission) announces the call for nominations seeking candidates for the Board of Commissioners. ... individuals with passion, skills and experience with diversity of clinical practice settings and ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... ... 11, 2016 , ... Greenfield Insurance Group in Orange City, ... the people of their local community. The agency pledges to select a new ... hope is to bring awareness to important local causes with fundraising and other ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... and updated its hallmark resource, Infusion Therapy Standards of Practice, to include vascular ... vein illumination with an estimated 85% share of the market, facilitates adherence to ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... YORK , Feb. 11, 2016 ... instruments commonly used in laboratories. These may range from ... condensers. Laboratory glassware is made from borosilicate glass because ... Laboratory plasticware, on the other hand, started gaining popularity ... it was easier to replace glass with plastic in ...
(Date:2/11/2016)... Feb. 11, 2016   Health 2.0 , the ... health technologies, announced today " 10 Year Global Retrospective ... tech over the past ten years.   ... decade, Health 2.0 has served as the preeminent thought-leader ... with thousands of technologies, companies, innovators, and patient-activists through ...
(Date:2/11/2016)... , Feb. 11, 2016 AAIPharma Services ... of custom manufacturing and development services for the ... fill-finish capabilities and capacity in its ... demand has driven several recent investments. ... had one filling line with small-scale lyophilization. The ...
Breaking Medicine Technology: